Bacteremia Due to Viridans Streptococci That Are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with Cancer

We prospectively studied 260 episodes of bacteremia that occurred over a 6-year period in neutropenic patients with cancer. Twenty-three episodes were caused by viridans streptococci. Thirteen (57%) of these strains were penicillin-resistant (MICs of penicillin ranged from 0.25 µg/mL to 8 µg/mL). Te...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases Vol. 20; no. 5; pp. 1169 - 1173
Main Authors: Carratalá, Jordi, Alcaide, Fernando, Fernández-Sevilla, Alberto, Corbella, Xavier, Liñares, Josefina, Gudiol, Francesc
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-05-1995
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We prospectively studied 260 episodes of bacteremia that occurred over a 6-year period in neutropenic patients with cancer. Twenty-three episodes were caused by viridans streptococci. Thirteen (57%) of these strains were penicillin-resistant (MICs of penicillin ranged from 0.25 µg/mL to 8 µg/mL). Ten of the 13 penicillin-resistant strains (77%) were highly resistant to penicillin (MIC, ⩾4 µg/mL). Rates of bacteremia due to highly penicillin-resistant viridans streptococci increased significantly from zero episodes per 1,000 admissions in 1987 to 17 episodes per 1,000 admissions in 1992 (P = .003). In a comparison between penicillin-resistant and penicillin-susceptible viridans streptococci bacteremia, the administration of β-lactam antibiotics during the previous 2 weeks was the only factor significantly associated with penicillin-resistant cases: 9 (69%) of 13 patients with penicillin-resistant bacteremia had received β-lactams vs. 2 (20%) of 10 patients with penicillin-susceptible bacteremia (P = .036). These findings may have significant clinical implications in the choice of both antimicrobial prophylaxis and empirical antibiotic regimens.
Bibliography:istex:E9A9D17AF7AB16F3D4A0F416CD70B16B18F6EB8B
ark:/67375/HXZ-HSSV6WNM-1
Reprints or correspondence: Dr. Jordi Carratalá, Infectious Disease Service, Hospital de Bellvitge, C/ Feixa Llarga s/n, 08907 L'Hospitalet, Barcelona, Spain.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1058-4838
1537-6591
DOI:10.1093/clinids/20.5.1169